4//SEC Filing
Savill Corrine 4
Accession 0000899243-23-005735
CIK 0001789972other
Filed
Feb 20, 7:00 PM ET
Accepted
Feb 21, 6:57 PM ET
Size
12.2 KB
Accession
0000899243-23-005735
Insider Transaction Report
Form 4
Savill Corrine
Chief Business Officer
Transactions
- Award
Common Stock
2023-02-17+20,500→ 170,115 total - Award
Stock Option (Right to Buy)
2023-02-17+41,000→ 41,000 totalExercise: $11.34Exp: 2033-02-16→ Common Stock (41,000 underlying)
Footnotes (2)
- [F1]The shares underlying the restricted stock unit vest over four years, with one forty-eighth (1/48th) of the shares vesting in equal monthly installments until the fourth anniversary of the grant date.
- [F2]The shares underlying the option vest over four years, with one forty-eighth (1/48th) of the shares vesting in equal monthly installments until the fourth anniversary of the grant date.
Issuer
Cullinan Oncology, Inc.
CIK 0001789972
Entity typeother
Related Parties
1- filerCIK 0001837524
Filing Metadata
- Form type
- 4
- Filed
- Feb 20, 7:00 PM ET
- Accepted
- Feb 21, 6:57 PM ET
- Size
- 12.2 KB